Wang, Q. et al. Metabolic heterogeneity in tumor cells impacts immunology in lung squamous cell carcinoma. OncoImmunology 14:2457797 (2025)
Krombach, J.* et al. Priming anti-tumor immunity by radiotherapy: Dying tumor cell-derived DAMPs trigger endothelial cell activation and recruitment of myeloid cells. OncoImmunology 8:e1523097 (2019)
Lilis, I.* et al. Interleukin-1β provided by KIT-competent mast cells is required for KRAS-mutant lung adenocarcinoma. OncoImmunology 8:1593802 (2019)
Liu, T.* et al. Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant chemotherapy. OncoImmunology 7:e1436922 (2018)
Giopanou, I.* et al. Tumor-derived osteopontin isoforms cooperate with TRP53 and CCL2 to promote lung metastasis. OncoImmunology 6:e1256528 (2017)
Bücklein, V.L. et al. Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients. OncoImmunology 5:e1178421 (2016)
Espinoza, J.A.* et al. Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics. OncoImmunology 5:e1248015 (2016)
Schirmer, D.* et al. Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity. OncoImmunology 5:e1175795 (2016)
Toma, M.* et al. Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis. OncoImmunology 4:e1008342 (2015)
Schendel, D.J. & Frankenberger, B. Limitations for TCR gene therapy by MHC-restricted fratricide and TCR-mediated hematopoietic stem cell toxicity. OncoImmunology 2:e22410 (2013)
Weißbrich, B.* ; Nauerth, M.* & Busch, D.H. Adoptive immunotherapy: New assay for the identification of T cells with optimal avidity. OncoImmunology 2:e26199 (2013)
Nößner, E. et al. Intratumoral alterations of dendritic-cell differentiation and CD8+ T-cell energy are immune escape mechanisms of clear cell renal cell carcinoma. OncoImmunology 1, 1451-1453 (2012)
Wilde, S. & Schendel, D.J. High-quality and high-avidity T cell clones specific for tumor-associated antigens and how to find them. OncoImmunology 1, 1643-1644 (2012)
Wilde, S. et al. Generation of allo-restricted peptide-specific T cells using RNA-pulsed dendritic cells: A three phase experimental procedure. OncoImmunology 1, 129-140 (2012)